Drug profile · INN
colchicine
COLCHICINE AGEPHA PHARMA
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
colchicine (COLCHICINE AGEPHA PHARMA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 11844771
Methods of treating acute respiratory distress syndrome using colchicine
granted -
US 11400063
Early administration of low-dose colchicine after myocardial infarction
granted -
US 9255063
Colchicine solid-state forms; methods of making; and methods of use thereof
granted -
US 8519002
Colchicine solid complex; methods of making; and methods of use thereof
granted -
US 8497290
Thiocolchicine derivatives, method of making and methods of use thereof
granted -
US 8445541
Methods for concomitant administration of colchicine and a second active agent
granted -
US 8440721
Methods for concomitant administration of colchicine and a second active agent
granted -
US 8440722
Methods for concomitant administration of colchicine and a second active agent
granted
Frequently asked questions
What is colchicine?
colchicine (COLCHICINE AGEPHA PHARMA) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for colchicine?
COLCHICINE AGEPHA PHARMA is a marketed brand name for colchicine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of colchicine?
colchicine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.